-
242 Articles
-
1 Photos
-
0 Vidéos
-
Female
-
16/09/2003
-
Suivi par 0 membre
Mises à jour récentes
-
Personalized Cell Therapy Market – Patient-Specific Treatments Redefining Modern MedicineMarket Overview The personalized cell therapy market is accelerating as treatments engineered from a patient's own cells move from experimental research into clinical practice. CAR-T therapies, tumor-infiltrating lymphocytes, and other autologous approaches offer new hope for cancers and other serious diseases. Advances in gene editing, cell engineering, and manufacturing are expanding what...0 Commentaires 0 Parts 661 Vue 0 AperçuConnectez-vous pour aimer, partager et commenter!
-
Capillary Stick Needle Market – Safer Blood Sampling Driving Lancet InnovationMarket Overview The capillary stick needle market is expanding as blood glucose monitoring, point-of-care testing, and neonatal screening increase worldwide. Capillary needles and lancets enable quick, minimally painful blood sampling from the fingertip or heel. Rising diabetes prevalence and self-testing habits are strengthening demand for safe, comfortable devices. The Capillary Stick Needle...0 Commentaires 0 Parts 724 Vue 0 Aperçu
-
Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market – Novel Agents Transforming Platelet Disorder CareMarket Overview The idiopathic thrombocytopenic purpura therapeutics market is expanding as new treatment options improve care for patients with low platelet counts. ITP is an autoimmune disorder that can cause bruising, bleeding, and fatigue. Therapies include corticosteroids, immunoglobulins, thrombopoietin receptor agonists, and emerging targeted agents. The Idiopathic Thrombocytopenic...0 Commentaires 0 Parts 674 Vue 0 Aperçu
-
Lactate Dehydrogenase Reagents Market – Diagnostic Testing Expansion Across Clinical LaboratoriesMarket Overview The lactate dehydrogenase reagents market is growing as clinical laboratories expand enzyme testing for tissue damage, hemolysis, liver disease, cancer monitoring, and cardiac assessment. LDH is a widely used biomarker, and reliable reagents are essential for accurate results. Rising chronic disease burden and higher diagnostic testing volumes are strengthening demand. The...0 Commentaires 0 Parts 667 Vue 0 Aperçu
-
Mosquito Artery Forcep Market – Essential Hemostatic Tools Sustaining Surgical DemandMarket Overview The mosquito artery forcep market is growing as surgical and dental procedures continue to rise worldwide. These small, fine-tipped hemostatic forceps are used to clamp small vessels, control bleeding, and handle delicate tissue in general, plastic, pediatric, and gynecologic surgery. Their versatility makes them a staple in operating rooms and clinics. The Mosquito Artery...0 Commentaires 0 Parts 686 Vue 0 Aperçu
-
Companion Animal Internal Dewormer Market – Pet Ownership Growth Fuels Parasite Control DemandMarket Overview The companion animal internal dewormer market is expanding as pet ownership rises and owners invest more in preventive health. Internal parasites such as roundworms, hookworms, whipworms, and tapeworms threaten pets and can spread to humans. Veterinary guidance emphasizing routine parasite control, alongside the humanization of pets, is driving steady demand. The Companion...0 Commentaires 0 Parts 668 Vue 0 Aperçu
-
Vigabatrin Market – Rising Demand in Infantile Spasms and Refractory Epilepsy TreatmentMarket Overview The vigabatrin market is advancing as neurologists seek effective therapies for infantile spasms and refractory complex partial seizures. Vigabatrin, a GABA transaminase inhibitor, is a critical option when other antiepileptic drugs fail, particularly in pediatric neurology. Demand is supported by improved early diagnosis, established treatment guidelines, and growing attention...0 Commentaires 0 Parts 649 Vue 0 Aperçu
-
Tardive Dyskinesia Treatment Drugs Market – VMAT2 Inhibitors Reshaping Movement Disorder CareMarket Overview The tardive dyskinesia treatment drugs market is expanding as awareness of antipsychotic-induced movement disorders grows among clinicians, caregivers, and patients. VMAT2 inhibitors have transformed care by offering targeted symptom control where physicians once relied on dose reduction or medication switching. Growth is supported by long-term antipsychotic use, structured...0 Commentaires 0 Parts 671 Vue 0 Aperçu
-
India Dry Age-Related Macular Degeneration AMD Market – Telemedicine Expanding Access to SpecialistsMarket OverviewTelemedicine is expanding access to specialists in the India dry age-related macular degeneration (AMD) market, addressing geographic barriers to care. Many patients in rural areas lack access to ophthalmologists, leading to delayed diagnosis and treatment. Teleophthalmology enables remote consultations, retinal imaging review, and treatment planning. The market is projected to...0 Commentaires 0 Parts 636 Vue 0 Aperçu
-
GCC Theranostics Market – Radiotheranostics Expanding in OncologyMarket OverviewRadiotheranostics is expanding in the GCC theranostics market, offering targeted radiation therapy guided by diagnostic imaging. This approach pairs a diagnostic radiopharmaceutical with a therapeutic counterpart, enabling precise tumor targeting while sparing healthy tissue. The market is projected to grow through 2030, fueled by clinical adoption and infrastructure investment....0 Commentaires 0 Parts 727 Vue 0 Aperçu
-
South America Remote Patient Monitoring Market – Wearable Devices Driving InnovationMarket OverviewWearable devices are driving innovation in the South America remote patient monitoring (RPM) market, enabling continuous, non-invasive monitoring of vital signs and activity. Devices including smartwatches, patches, and biosensors are expanding the range of metrics that can be monitored remotely. The market is projected to grow through 2030, fueled by consumer adoption and...0 Commentaires 0 Parts 707 Vue 0 Aperçu
-
UK Lupus Market – Biologics and Novel Therapies Transforming CareMarket OverviewBiologics and novel therapies are transforming the UK lupus market, offering targeted treatment options for patients with inadequate responses to conventional immunosuppressants. Belimumab and anifrolumab represent significant advances, reducing disease activity and steroid dependence. The market is projected to grow through 2030, fueled by clinical research and expanded NHS...0 Commentaires 0 Parts 634 Vue 0 Aperçu
Plus de lecture